Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 196 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

5%

10 trials in Phase 3/4

Results Transparency

3%

1 of 30 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

155Total
Not Applicable (126)
Early P 1 (1)
P 1 (10)
P 2 (8)
P 3 (2)
P 4 (8)

Trial Status

Recruiting77
Not Yet Recruiting60
Completed30
Active Not Recruiting14
Enrolling By Invitation13
Withdrawn2

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 30 completed trials

Clinical Trials (196)

Showing 20 of 20 trials
NCT06909669Not ApplicableRecruitingPrimary

Ultra-brief Psychological Treatments for Emotional Symptoms and Disorders

NCT07631247Not ApplicableNot Yet RecruitingPrimary

iPath for CP Pilot

NCT07844733Not ApplicableNot Yet RecruitingPrimary

Slow-Paced Breathing and Electrical Vagus Nerve Stimulation as Add-on Treatments for Depression

NCT06835855Not ApplicableRecruitingPrimary

Development of Attentional Biases for Affective Cues in Infants of Mothers With Depression

NCT07848477Not ApplicableNot Yet Recruiting

PROMOTE: Effects of 5-HT4 Agonism on Cognition and Sleep in Peopl With Low Mood

NCT06967857Phase 2Recruiting

Clinical Trial to Investigate the Safety and Efficacy of Two Dexamfetamine Sulfate Formulations in Adults With ADHD and Moderate to Severe Depression

NCT06793397Phase 3Recruiting

A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

NCT07657234Phase 1Recruiting

tDCS for Late-Life Depression

NCT07680140Phase 4RecruitingPrimary

Biomarker-Guided Antidepressant Selection

NCT07639606Not ApplicableRecruiting

Mobile Cognitive Behavioral Therapy in Early Stroke Recovery

NCT07834684RecruitingPrimary

Singula Phase 0.1 Primary Care Pilot

NCT07779707Not ApplicableRecruitingPrimary

The Medically Tailored Groceries and Mental Health Study

NCT07210112Phase 2RecruitingPrimary

Efficacy of Psilocybin and Trazodone Combination in Treatment-resistant Depression: a Randomized Controlled Proof-of-concept Study (PSILOTRAZ)

NCT07474974Not ApplicableRecruitingPrimary

ipRGC as a Potential Biomarker for Predicting Transcranial Magnetic Stimulation Treatment Response in Major Depressive Disorder

NCT07623135Phase 3Recruiting

Lumateperone for Late-Life Depression

NCT07823218Not Yet RecruitingPrimary

Longitudinal Effects of Brain Stimulation on Decision-Making and Reward Learning

NCT03537794Recruiting

Characterizing Synaptic Density in Treatment Resistant Depression

NCT07373470Not ApplicableRecruiting

An Evaluation of the Impact of Pharmacist Comprehensive Medication Management With Pharmacogenomic Results to Improve Depression Outcomes in Community Pharmacies.

NCT06675240Not ApplicableRecruitingPrimary

Meditative Neurofeedback for Depression

NCT07812311Not ApplicableActive Not RecruitingPrimary

Evaluating the Effects of StrongMinds Community-Based Group Interpersonal Therapy on Depression and Secondary Outcomes in Uganda

Scroll to load more

Research Network

Activity Timeline